Text Module


Share

Program Content

Activities

  • AEs With ICI/Targeted Tx
    Expert Strategies for Managing Adverse Events With Combination Immune Checkpoint Inhibitor/Targeted Therapy
    Text Module
    Congratulations: You achieved a completion on 04/09/2022

    Released: May 25, 2023

    Expires: May 24, 2024

Faculty

cover img faculity

Eric Jonasch, MD

Professor, Department of GU Medical Oncology
The University of Texas
MD Anderson Cancer Center
Houston, Texas

cover img faculity

Kathleen N. Moore, MD, MS

Virginia Kerley Cade Chair in Developmental Therapeutics
Deputy Director
Associate Director Clinical Research
Stephenson Cancer Center at OU Health
Oklahoma City, Oklahoma

Provided by

ProCE Banner

Supporters

Supported by educational grants from AstraZeneca, Eisai, Merck Sharp & Dohme LLC, and Regeneron Pharmaceuticals, Inc.

AstraZeneca

Eisai

Merck Sharp & Dohme, LLC

Regeneron Pharmaceuticals, Inc